Mersana Therapeutics buy Guggenheim
Start price
14.06.23
/
50%
€5.54
Target price
14.06.24
-
Performance (%)
-66.10%
End price
15.06.24
€1.88
Summary
This prediction ended on 15.06.24 with a price of €1.88. The BUY prediction by Guggenheim for Mersana Therapeutics performed very badly with a performance of -66.10%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | -2.434% | -2.434% | -42.997% |
| iShares Core DAX® | -0.079% | -3.039% | 13.992% |
| iShares Nasdaq 100 | 0.247% | 6.421% | 36.232% |
| iShares Nikkei 225® | 1.918% | 0.675% | 10.784% |
| iShares S&P 500 | 0.146% | 4.708% | 29.832% |
Comments by Guggenheim for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten